Phase I/II trial of intravenous Doxil® and whole abdomen hyperthermia in patients with refractory ovarian cancer - Concepedia

Concepedia

Publication | Closed Access

Phase I/II trial of intravenous Doxil® and whole abdomen hyperthermia in patients with refractory ovarian cancer

34

Citations

22

References

2005

Year

Angeles Alvarez Secord, Ellen L. Jones, Carol A. Hahn, William P. Petros, Daohai Yu, L.J. Havrilesky, John T. Soper, A. Berchuck, Ivan Spasojević, Daniel L. Clarke‐Pearson,

International Journal of Hyperthermia

Abstract

Therapy with intravenous Doxil and whole abdomen hyperthermia for patients with platinum/paclitaxel resistant ovarian cancer is feasible and does not negatively impact quality of life.

References

	Year	Citations

Page 1